Lista de

Drug Synergism
21
"Cooperative behavior of fluoroquinolone combinations against Escherichia coli and Staphylococcus aureus" (2017) Vitorino, G.P.;Becerra, M.C.;Barrera, G.D. (...)Mazzieri, M.R. Biological and Pharmaceutical Bulletin. 40(6):758-764
"Synergistic Antiproliferative Effects of a New Cucurbitacin B Derivative and Chemotherapy Drugs on Lung Cancer Cell Line A549" (2015) Marostica, L.L.;Silva, I.T.;Kratz, J.M. (...)Simões, C.M.O. Chemical Research in Toxicology. 28(10):1949-1960
"Polyoxygenated steroids from the octocoral leptogorgia punicea and in vitro evaluation of their cytotoxic activity" (2014) Moritz, M.I.G.;Marostica, L.L.;Bianco, É.M. (...)Schenkel, E.P. Marine Drugs. 12(12):5864-5880
"Glyphosate commercial formulation causes cytotoxicity, oxidative effects, and apoptosis on human cells: Differences with its active ingredient" (2014) Chaufan, G.; Coalova, I.; Del Carmen Ríos De Molina, M. International Journal of Toxicology. 33(1):29-38
"Binary mixtures of azinphos-methyl oxon and chlorpyrifos oxon produce in vitro synergistic cholinesterase inhibition in Planorbarius corneus" (2012) Cacciatore, L.C.; Kristoff, G.; Verrengia Guerrero, N.R.; Cochón, A.C. Chemosphere. 88(4):450-458
"Synergistic effect of surfactin from Bacillus subtilis C4 and Achyrocline satureioides extracts on the viability of Paenibacillus larvae" (2012) Sabaté, D.C.;Gonzaléz, M.J.;Porrini, M.P. (...)Marioli, J.M. World Journal of Microbiology and Biotechnology. 28(4):1415-1422
"Overcoming the hurdles of tumor immunity by targeting regulatory pathways in innate and adaptive immune cells" (2010) Zwirner, N.W.; Croci, D.O.; Domaica, C.I.; Rabinovich, G.A. Current Pharmaceutical Design. 16(3):255-267
"Two immunomodulators, curcumin and sulfasalazine, enhance IDV antiretroviral activity in HIV-1 persistently infected cells" (2008) Riva, D.A.;Fernández-Larrosa, P.N.;Dolcini, G.L. (...)Mersich, S.E. Archives of Virology. 153(3):561-565
"Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis" (2008) Garay, L.;Gonzalez Deniselle, M.C.;Gierman, L. (...)De Nicola, A.F. NeuroImmunoModulation. 15(1):76-83
"Mixtures of natural and synthetic antifungal agents" (2005) López-Malo, A.; Palou, E.; León-Cruz, R.; Alzamora, S.M. Advances in Experimental Medicine and Biology. 571:261-286
"Sex-linked differences in the vasorelaxant effects of anandamide in vascular mesenteric beds: Role of oestrogens" (2004) Peroni, R.N.;Orliac, M.L.;Becu-Villalobos, D. (...)Celuch, S.M. European Journal of Pharmacology. 493(1-3):151-160
"Interferon-alpha 2b modulation of doxorubicin sensitivity in a multidrug resistant cell line" (2001) Gritti, M.F.L.; Beviacqua, M.; Bordenave, R.H.; Rumi, L.S. Journal of Experimental and Clinical Cancer Research. 20(3):393-400
"Octopamine and Phenylethylamine Inhibit Prolactin Secretion both In Vivo and In Vitro" (1992) Becú-Villalobos, D.;Thyssen, S.M.;Rey, E.B. (...)Libertun, C. Proceedings of the Society for Experimental Biology and Medicine. 199(2):230-235
"Cholinesterase inhibition by phenothiazine and nonphenothiazine antihistaminics: Analysis of its postulated role in synergizing organophosphate toxicity" (1975) Fernández, G.; Díaz Gómez, M.I.; Castro, JosA. Toxicology and Applied Pharmacology. 31(2):179-190